SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc

<< Previous

Bullboard Posts

Next >>

Post by FactFinder1994on Dec 07, 2022 12:57pm

130 Views

Post# 35156711

Perspective on timing....from 2021 MD&A

RALI-Dx Severity Triage Tests has already been submitted to the FDA once. The need for this product now is bigger than it was then. To think that the level of crisis could be lowered with this product, yet all remains quiet....For the sake of humankind, speak up!

In the fourth quarter of fiscal 2020, the Company worked in partnership with UHN and shipped kits to them for its RALI-DxTM IL-6 Severity Triage Test, to complete the research and testing required for submission to FDA. The submission to FDA took place in March 2021, therefore, there was no further research related revenue recognized for RALI -DxTM IL-6 Severity Triage Test in the fourth quarter of fiscal 2021.

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?